Sleep disturbances in depression and the effects of antidepressants

References

• Agargun, M. Y., Kara, H., & Solmaz, M. (1997). Subjective sleep quality and suicidality in patients with major depression. Journal of Psychiatric Research, 31, 377–381.
   PubMed Web of Science ®Google Scholar
• Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., et al. (1993). Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. International Clinical Psychopharmacology, 8, 197–202.
   PubMed Web of Science ®Google Scholar
• Akerstedt, T., Hume, K., Minors, D., & Waterhouse, J. (1994). The subjective meaning of good sleep, an intra-individual approach using the Karolinska Sleep Diary. Perceptual and Motor Skills, 79,287–296.
   PubMed Web of Science ®Google Scholar
• Argyropoulos, S. V., Hicks, J. A., Nash, J. R., Bell, C. J., Rich, A. S., Nutt, D. J., et al. (2003). Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Research, 120, 179–190.
   PubMed Web of Science ®Google Scholar
• Armitage, R. (1995). Micro-architectural findings in sleep EEG in depression: Diagnostic implications. Biological Psychiatry, 37, 72–84.
   PubMedGoogle Scholar
• Armitage, R., Trivedi, M., Hoffmann, R., SE Rush, A. J. (1997). Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depression and Anxiety, 5,97–102.
   PubMedGoogle Scholar
• Baldwin, D. S., Hawley, C. J., Abed, R. T., Maragakis, B. P., Cox, J., Buckingham, S. A., et al. (1996). A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression. Journal of Clinical Psychiatry, 57 (Suppl. 2), 46–52.
   Google Scholar
• Bech, P., & Cialdella, P. (1992). Citalopram in depression-meta-analysis of intended and unintended effects. International Clinical Psychopharmacology, 6 (Suppl. 5), 45–54.
   Google Scholar
• Benca, R. M., Obermeyer, W. H., Thisted, R. A., & Gillin, J. C. (1992). Sleep and psychiatric disorders. A meta-analysis. Archives of General Psychiatry, 49, 651–668.
   PubMed Web of Science ®Google Scholar
• Bennie, E. H., Mullin, J. M., & Martindale, J. J. (1995). A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. Journal of Clinical Psychiatry, 56,229–237.
   PubMed Web of Science ®Google Scholar
• Blacker, R., Shanks, N. J., Chapman, N., & Davey, A. (1988). The drug treatment of depression in general practice: A comparison of nocte administration of trazodone with mian-serin, dothiepin and amitriptyline. Psychopharmacology (Berl), 95(Suppl.), S18–S24.
   Google Scholar
• Borbély, A. A., & Achermann, P. (1999). Sleep homeostasis and models of sleep regulation. Journal of Biological Rhythms, 14, 557–568.
   Google Scholar
• Brunello, N., Armitage, R., Feinberg, I., Holsboer-Trachsler, E., Leger, D., Linkowski, P., et al. (2000). Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology, 42, 107–119.
   Google Scholar
• Buysse, D. J., Frank, E., Lowe, K. K., Cherry, C. R., & Kupfer, D. J. (1997). Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biological Psychiatry, 41, 406–418.
   PubMed Web of Science ®Google Scholar
• Buysse, D. J., Kupfer, D. J., Frank, E., Monk, T. H., Ritenour, A., & Ehlers, C. L. (1992). Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy: I. Baseline studies in responders and non-responders. Psychiatry Research, 42, 13–26.
   Google Scholar
• Buysse, D. J., Reynolds III, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28, 193–213.
   Google Scholar
• Dorman, T. (1992). Sleep and paroxetine: A comparison with mianserin in elderly depressed patients. International Clinical Psychopharmacology, 6 (Suppl. 4), 53–58.
   Google Scholar
• Dossenbach, M., Martenyi, F. S., & De Verga, E. (1997). Sleep quality during fluoxetine therapy in depression. Biological Psychiatry, 42, 243S.
   Google Scholar
• Ehlers, C. L., Havstad, J. W., & Kupfer, D. J. (1996). Estimation of the time course of slow-wave sleep over the night in depressed
   Google Scholar
• patients: Effects of clomipramine and clinical response. Biological Psychiatry, 39,171–181.
   Google Scholar
• Feige, B., Voderholzer, U., Riemann, D., Dittmann, R., Hohagen, F., & Berger, M. (2002). Fluoxetine and sleep EEG: Effects of a single dose, sub-chronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology, 26, 246–258.
   Google Scholar
• Ford, D. E., & Cooper-Patrick, L. (2001). Sleep disturbances and mood disorders: An epidemiologic perspective. Depression and Anxiety, 14, 3–6.
   Google Scholar
• Giles, D. E., Kupfer, D. J., Roffwarg, H. P., Rush, A. J., Biggs, M. M., & Etzel, B. A. (1989). Polysomnographic parameters in first-degree relatives of unipolar probands. Psychiatry Research, 27, 127–136.
   Google Scholar
• Gillin, J. C., Jernajczyk, W., Valladares-Neto, D. C., Golshan, S., Lardon, M., & Stahl, S. M. (1994). Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers. Psychopharmacology (Ben), 116, 433–436.
   Google Scholar
• Guelfi, J. D., Ansseau, M., Timmerman, L., & Korsgaard, S. (2001). Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Journal of Clinical Psychopharmacology, 21, 425–431.
   PubMed Web of Science ®Google Scholar
• Haas, H., & Panula, P. (2003). The role of histamine and the tuberomamillary nucleus in the nervous system. Nature Reviews of Neuroscience, 4, 121–130.
   PubMed Web of Science ®Google Scholar
• Hajak, G., Rodenbeck, A., Voderholzer, U., Riemann, D., Cohrs, S., Hohagen, F., et al. (2001). Doxepin in the treatment of primary insomnia: A placebo-controlled, double-blind, polysomnographic study. Journal of Clinical Psychiatry, 62, 453–463.
   PubMed Web of Science ®Google Scholar
• Hamilton, M. (1989). Frequency of symptoms in melancholia (depressive illness). British Journal of Psychiatry, 154, 201–206.
   PubMed Web of Science ®Google Scholar
• Hicks, J. A., Argyropoulos, S. V., Rich, A. S., Nash, J. R., Bell, C. J., Edwards, C., et al. (2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. British Journal of Psychiatry, 180, 528–535.
   PubMed Web of Science ®Google Scholar
• Hobson, J. A., Stickgold, R., & Pace, S. (1998). The neuropsy-chology of REM sleep dreaming. NeuroReport, 9, R1–R14.
   Google Scholar
• Hochli, D., Riemann, D., Zulley, J., & Berger, M. (1986). Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients? Acta Psychiatrica Scandinavica, 74, 190–192.
   Google Scholar
• Hutchinson, D. R., Tong, S., Moon, C. A., Vince, M., & Clarke, A. (1992). Paroxetine in the treatment of elderly depressed patients in general practice: A double-blind comparison with amitriptyline. International Clinical Psychopharmacology, 6 (Suppl. 4), 43–51.
   Google Scholar
• Jindal, R. D., Friedman, E. S., Berman, S. R., Fasiczka, A. L., Howland, R. H., & Thase, M. E. (2003). Effects of sertraline on sleep architecture in patients with depression. Journal of Clinical Psychopharmacology, 23, 540–548.
   PubMed Web of Science ®Google Scholar
• Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., et al. (2002). Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry, 51, 237–252.
   PubMed Web of Science ®Google Scholar
• Kupfer, D. J., & Ehlers, C. L. (1989). Two roads to rapid eye movement latency. Archives of General Psychiatry, 46,945–948.
   PubMed Web of Science ®Google Scholar
• Kupfer, D. J., Ehlers, C. L., Frank, E., Grochocinski, V. J., McEachran, A. B., & Buhari, A. (1993). Electroencephalographic sleep studies in depressed patients during long-term recovery. Psychiatry Research, 49, 121–138.
   PubMedGoogle Scholar
• Kupfer, D. J., Frank, E., McEachran, A. B., & Grochocinski, V. J. (1990). Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Archives of General Psychiatry, 47, 1100–1105.
   PubMed Web of Science ®Google Scholar
• Kupfer, D. J., Perel, J. M., Pollock, B. G., Nathan, R. S., Grochocinski, V. J., Wilson, M. J., et al. (1991). Fluvoxamine versus desipramine: Comparative polysomnographic effects. Biological Psychiatry, 29, 23–40.
   Google Scholar
• Kupfer, D. J., Spiker, D. G., Coble, P. A., Neil, J. F., Ulrich, R., & Shaw, D. H. (1981). Sleep and treatment prediction in endogenous depression. American Journal of Psychiatry, 138, 429–434.
   PubMed Web of Science ®Google Scholar
• Landolt, H. P., Kelsoe, J. R., Rapaport, M. H., & Gillin, J. C. (2003). Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. Journal of Sleep Research, 12, 13–18.
   PubMed Web of Science ®Google Scholar
• Landolt, H. P., Raimo, E. B., Schnierow, B. J., Kelsoe, J. R., Rapaport, M. H., & Gillin, J. C. (2001). Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Archives of General Psychiatry, 58, 268–276.
   PubMed Web of Science ®Google Scholar
• Lauer, C. J., Schreiber, W., Holsboer, F., & Krieg, J. C. (1995). In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Archives of General Psychiatry, 52, 145–153.
   PubMed Web of Science ®Google Scholar
• Leigh, T. J., Bird, H. A., Hindmarch, I., Constable, P. D., & Wright, V. (1988). Factor analysis of the St. Mary's Hospital Sleep Questionnaire. Sleep, 11, 448–453.
   PubMed Web of Science ®Google Scholar
• Lepine, J. P., Gastpar, M., Mendlewicz, J., & Tylee, A. (1997). Depression in the community: The first pan-European study DEPRES (Depression Research in European Society). International Clinical Psychopharmacology, 12, 19–29.
   PubMed Web of Science ®Google Scholar
• Linkowski, P., Kerkhofs, M., Hauspie, R., & Mendlewicz, J. (1991). Genetic determinants of EEG sleep: A study in twins living apart. Electroencephalography and Clinical Neurophysiology, 79,114–118.
   Google Scholar
• Manber, R., Rush, A. J., Thase, M. E., Amow, B., Klein, D., Trivedi, M. H., et al. (2003). The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep, 26, 130–136.
   Google Scholar
• Maquet, P., Degueldre, C., Delfiore, G., Aerts, J., Peters, J. M., Luxen, A., et al. (1997). Functional neuroanatomy of human slow wave sleep. The Journal of Neuroscience, 17, 2807–2812.
   PubMed Web of Science ®Google Scholar
• Mayers, A. G., Van Hooff, J. C., & Baldwin, D. S. (2003). Quantifying subjective assessment of sleep and life-quality in antidepressant-treated depressed patients. Human Psychopharmacology, 18, 21–27.
   Google Scholar
• Mendlewicz, J., Kempenaers, C., & De Maertelaer, V. (1991). Sleep EEG and amitryptiline treatment in depressed inpatients. Biological Psychiatry, 30, 691–702.
   Google Scholar
• Monaca, C., Boutrel, B., Hen, R., Hamon, M., & Adrien, J. (2003). 5-HTINIB receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: Studies in 5-HT1A and 5-HT1B knockout mice. Neuropsychopharmacology, 28, 850–856.
   PubMedGoogle Scholar
• Moore, P., Gillin, C., Bhatti, T., Demodena, A., Seifritz, E., Clark, C., et al. (1998). Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Archives of General Psychiatry, 55, 534–539.
   PubMed Web of Science ®Google Scholar
• Nierenberg, A. A., Adler, L. A., Peselow, E., Zornberg, G., & Rosenthal, M. (1994). Trazodone for antidepressant-associated insomnia. American Journal of Psychiatry, 151, 1069–1072.
   PubMed Web of Science ®Google Scholar
• Nissen, C., Feige, B., Konig, A., Voderholzer, U., Berger, M., & Riemann, D. (2001). Delta sleep ratio as a predictor of sleep deprivation response in major depression. Journal of Psychiatric Research, 35,155–163.
   PubMed Web of Science ®Google Scholar
• Nofzinger, E. A., Reynolds III, C. F., Thase, M. E., Frank, E., Jennings, J. R., Fasiczka, A. L., et al. (1995). REM sleep enhancement by bupropion in depressed men. American Journal of Psychiatry, 152, 274–276.
   Web of Science ®Google Scholar
• Oberndorfer, S., Saletu-Zyhlarz, G., & Saletu, B. (2000). Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology, 42, 69–81.
   Google Scholar
• Ott, G. E., Rao, U., Lin, K. M., Gertsik, L., & Poland, R. E. (2004). Effect of treatment with bupropion on EEG sleep: Relationship to antidepressant response. International Journal of Neuropsychopharmacology, 7,275–281.
   Google Scholar
• Parrott, A. C., & Hindmarch, I. (1980). The Leeds Sleep Evaluation Questionnaire in psychopharmacological investiga-tions-a review. Psychopharmacology (Ben), 71, 173–179.
   PubMed Web of Science ®Google Scholar
• Reynolds III, C. F., & Kupfer, D. J. (1987). Sleep research in affective illness: State of the art circa 1987. Sleep, 10, 199–215.
   Google Scholar
• Riemann, D., Voderholzer, U., Cohrs, S., Rodenbeck, A., Hajak, G., Ruther, E., et al. (2002). Trimipramine in primary insomnia: Results of a polysomnographic double-blind controlled study. Pharmacopsychiatg, 35, 165–174.
   PubMed Web of Science ®Google Scholar
• Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgard, S. (1994). Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study. International Clinical Psychopharmacology, 9 (Suppl. 1), 41–48.
   Google Scholar
• Rush, A. J., Armitage, R., Gillin, J. C., Yonkers, K. A., Winokur, A., Moldofsky, H., et al. (1998). Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biological Psychiatry, 44, 3–14.
   PubMed Web of Science ®Google Scholar
• Sateia, M. J., Doghramji, K., Hauri, P. J., & Morin, C. M. (2000). Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep, 23, 243–308.
   PubMed Web of Science ®Google Scholar
• Satterlee, W. G., & Faries, D. (1995). The effects of fluoxetine on symptoms of insomnia in depressed patients. Psychopharmacology Bulletin, 31, 227–237.
   PubMedGoogle Scholar
• Schittecatte, M., Dumont, F., Machowski, R., Cornil, C., Lavergne, F., & Wilmotte, J. (2002). Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology, 46, 197–201.
   PubMed Web of Science ®Google Scholar
• Sechter, D., Troy, S., Paternetti, S., & Boyer, P. (1999). A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. European Psychiatry, 14, 41–48.
   PubMed Web of Science ®Google Scholar
• Seifritz, E. (2001). Contribution of sleep physiology to depressive pathophysiology. Neuropsychopharmacology, 25, S85–S88.
   Google Scholar
• Sharpley, A. L., Solomon, R. A., & Cowen, P. J. (1988). Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep, 11, 273–276.
   PubMedGoogle Scholar
• Sharpley, A. L., Vassallo, C. M., & Cowen, P. J. (2000). Olanzapine increases slow-wave sleep: Evidence for blockade of central 5-HT(2c) receptors in vivo. Biological Psychiatry, 47, 468–470.
   PubMed Web of Science ®Google Scholar
• Sogaard, J., Lane, R., Latimer, P., Behnke, K., Christiansen, P. E., Nielsen, B., et al. (1999). A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. Journal of Psychopharmacology, 13, 406–414.
   PubMed Web of Science ®Google Scholar
• Soldatos, C. R., Dikeos, D. G., & Paparrigopoulos, T. J. (2000). Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. Journal of Psychosomatic Research, 48, 555–560.
   PubMed Web of Science ®Google Scholar
• Staner, L., Kerkhofs, M., Detroux, D., L,eyman, S., Linkowski, P., & Mendlewicz, J. (1995). Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression. Sleep, 18, 470–477.
   Google Scholar
• Staner, L., Luthringer, R., & Macher, J.-P. (1999). Effects of antidepressant drugs on sleep EEG in patients with major depression. CNS Drugs, 11, 49–60.
   Google Scholar
• Stephenson, D. A., Harris, B., Davies, R. H., Mullin, J. M., Richardson, E., Boardman, H., et al. (2000). The impact of antidepressants on sleep and anxiety: A comparative study of fluoxetine and dothiepin using the Leeds Sleep Evaluation Questionnaire. Human Psychopharmacology, 15, 529–534.
   Google Scholar
• Thase, M. E. (1999). Antidepressant treatment of the depressed patient with insomnia. Journal of Clinical Psychiatry, 60 (Suppl. 17), 28–31.
   Google Scholar
• Thase, M. E., Fasiczka, A. L., Berman, S. R., Simons, A. D., & Reynolds III, C. F.. (1998). Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Archives of General Psychiatry, 55, 138–144.
   Google Scholar
• Van Bemmel, A. L. (1997). The link between sleep and depression: The effects of antidepressants on EEG sleep. Journal of Psychosomatic Research, 42, 555–564.
   Google Scholar
• Van Bemmel, A. L., Van Den Hoofdakker, R. H., Beersma, D. G., & Bouhuys, A. L. (1993). Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology (Berl), 113, 225–230.
   Google Scholar
• Veitch, W., Wilson, S. J., Argyropoulos, S., Nash, J., Hicks, J., & Nutt, D. J. (2001). Slow waves in sleep are altered by paroxetine and nefazodone in depressed patients. Journal of Psychopharmacology (Oxf), 15, A18.
   Google Scholar
• Vogal, G., Cohen, J., Mullis, D., Kensler, T., & Kaplita, S. (1998). Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep? Sleep, 21, 70–77.
   Google Scholar
• Ware, J. C. (1983). Tricyclic antidepressants in the treatment of insomnia. Journal of Clinical Psychiatry, 44, 25–28.
   PubMed Web of Science ®Google Scholar
• Ware, J. C., Brown, F. W., Moorad Jr, P. J., Pittard, J. T., & Cobert, B. (1989). Effects on sleep: A double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep, 12, 537–549.
   Google Scholar
• Wilson, S. J., Bailey, J. E., Rich, A. S., Adrover, M., Potokar, J., & Nutt, D. J. (2004). Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. European Neuropsychopharmacology, 14, 367–372.
   PubMedGoogle Scholar
• Wilson, S. J., Bell, C., Coupland, N. J., & Nutt, D. J. (2000). Sleep changes during long-term treatment of depression with fluvoxamine-a home-based study. Psychopharmacology (Berl), 149, 360–365.
   PubMed Web of Science ®Google Scholar
• Zisapel, N., & Laudon, M. (2003). Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: A review. Human Psychopharmacology, 18, 1–20.
   PubMed Web of Science ®Google Scholar